Speaker Guidelines

Scientific sessions

Coronavirus 2021 invites speakers to submit abstract on the following sessions but not limited to:

Viral Epidemiology | Submit

Viral epidemiology is the scientific discipline concerned with the study of the incidence and spread of viruses in populations over time. Host, virus and environmental factors are monitored to determine the dynamics of viral infections, the ultimate goal of which is to devise intervention strategies. The session includes virus transmission, mechanisms of survival of viruses in nature, emerging viral diseases, Epidemiological Characteristics of diseases.

  • Viral Community Structure
  • Viral Phylogeny/Cophylogeny
  • Evolution of Viruses and Emergence of Genetic Variants
  • Classifying Mechanisms of Viral Transmission
  • New, Emerging, and Reemerging Viruses
  • Virological Determinants of the Emergence of Viral Disease
  • Quantification of Characteristics of Viral Infection
  • Observational Epidemiology
  • Experimental Epidemiology
  • Epidemiological Characteristics of Respiratory Viruses

Clinical Virology | Submit

Virology that pertains to virus-induced clinical conditions. It includes the study of resistance of viruses in treatment antiviral by viral genome sequencing, viral pathogenesis and viral immunology. The session includes topics like various cultures, serological, biochemical and molecular studies. This field is very useful in knowing the epidemiology and spreading of viral diseases.

  • Screening of virus
  • Viral genomics
  • Detection and Molecular Typing
  • Laboratory Findings and Diagnosis

Viral Pathogenesis | Submit

Pathogenesis is the process by which an infection leads to disease. The session includes mechanisms of the virus entry, replication, spread to target organs and spread to sites of shedding of virus into the environment.

  • Cellular Pathogenesis
  • Sequence of Virus Spread in the Host
  • Implantation at the Portal of Entry
  • Local Replication and Local Spread
  • Incubation Period
  • Multiplication in Target Organs
  • Shedding of Virus
  • Neurovirology

Virus – host Interactions | Submit

Viruses display remarkable specificity in both the host species and the cell types that they infect. Understanding this specificity reveals insight into the basic host components that are required for the viral life cycle and host restriction factors that limit the virus. The sessions

  • Cell Biology of Viral Infection
  • Host Response to the virus
  • Virus replication complex formation
  • Coronavirus Replicase Protein Expression and Processing
  • Expression of Structural and Accessory Genes
  • Coronavirus Genetics

Immune response to infection | Submit

The immune response is how the human body recognizes and defends itself against these respiratory viruses that appear foreign and harmful.

  • Immune response to respiratory coronavirus
  • Innate and acquired immunity

Symptoms & Transmission | Submit

Human to human transmission of coronaviruses is primarily thought to occur among close contacts via respiratory droplets generated by sneezing and coughing. There are lots of symptoms other than fever, cold, cough and some have reported without symptoms. People who have underlying medical conditions and those over 60 years old have a higher risk of developing severe disease and death.

  • Fever
  • Dry cough
  • Shortness of breath
  • Sore throat
  • Chills
  • Diarrhea, Nausea or a runny nose

Respiratory Tract Infections | Submit

The talks include Severe acute respiratory syndrome (SERS) and Middle East respiratory syndrome (MERS) and their treatment and cure.

  • Biology of Acute Respiratory Infection
  • Immune hyperreactivity
  • Pulmonary destruction
  • ARI in children
  • Pneumonia
  • Risk for Acute Respiratory Infection
  • Diagnosis & Treatment

Mechanisms of Virus Replication | Submit

The track describes the formation of viruses during the infection process in target host cells as viral replication. The discussions involve multiplication within the host cell, viral populations, penetration.

  • Gene Expression
  • Transcription/Translation
  • Penetration

Clinical Infections | Submit

Coronavirus has a group of related viruses that causes the below infections. These topics will be discussed.

  • Middle East respiratory syndrome (MERS)
  • Severe acute respiratory syndrome coronavirus (SARS-CoV)
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Influenza virus
  • Pneumonia
  • Other respiratory diseases

Nosocomial infections | Submit

Hospital-related infections have been widely reported during the ongoing coronavirus outbreak, with healthcare professionals bearing a disproportionate risk.

  • Patient spread
  • Blood-borne
  • Respiratory tract infections
  • Respiratory Syncytial Virus
  • Enteric pathogens
  • Prevention of nosocomial infections

SARSr-CoV | Submit

SARS coronavirus (SARS-CoV) – virus identified in 2003. SARS-CoV is thought to be an animal virus from an as-yet-uncertain animal reservoir, perhaps bats, that spread to other animals (civet cats) and first infected humans in the Guangdong province of southern China in 2002. Their study, research and prevention will be discussed in this session.

  • Transmission & prevention
  • Diagnosis and Treatment
  • Testing and Health monitoring
  • Co-infections
  • Prevention
  • Treatment

MERS?CoV | Submit

Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a novel coronavirus (Middle East respiratory syndrome coronavirus, or MERS?CoV) that was first identified in Saudi Arabia. Their study, research and prevention will be discussed in this session.

  • Epidemiology & source of infection
  • Symptoms and complications
  • Risk factors & Transmission
  • Prevention and treatment

Coronavirus disease 2019 (COVID-19) | Submit

The COVID-19 pandemic, also known as the coronavirus pandemic, is an ongoing pandemic of coronavirus disease 2019 (COVID?19) which is caused by severe acute respiratory syndrome coronavirus 2 (SARS?CoV?2). This track describes about the causes, signs, symptoms, physiology, prevention and management, global social and economic disruption.

  • Epidemiology & Pathogenesis
  • Immune response to infection
  • Symptoms & Transmission
  • Respiratory Tract Infections
  • Treatment & Cure
  • Risk factors & Prevention

Epidemic outbreak of Covid19 | Submit

In humans, coronaviruses cause respiratory tract infections that can range from mild (common cold) to lethal (SARS, MERS, and COVID-19) and recover without requiring special treatment and in birds and mammals also cause various diseases. People with medical problems like diabetes, chronic respiratory disease, cardiovascular disease, and cancer and also in elder are more likely to develop serious illness. At present, no specific treatment is there for disease caused by a novel coronavirus.

  • Infections in High Risk Populations
  • Public safety
  • Isolation and quarantine
  • Mental health of Covid19 patients
  • Data management

Infection Control | Submit

This track includes topics which discusses control measures to prevent the infections from basic sanitization to surveillance, monitoring, and investigating any suspected outbreak of infection. And also about prevention of spread of infections, isolation and quarantine. Infection control prevents nosocomial or healthcare-associated with infection, a practical (rather than academic) sub-discipline of epidemiology.

Infection control and Hospital epidemiology are related to the general public health practice. The infection management relevants to the spreading of infections, either within the hospitals or alternative aid centres, as well as difficulty via hand hygiene, cleansing or disinfection or sanitization, vaccines or surveillance and probe of infections in a health-care domain.

  • Hand hygiene
  • Sterilization
  • Cleaning
  • Disinfection
  • Personal protective equipment
  • Antimicrobial surfaces
  • Ambulatory care settings
  • Alternative care settings

Anti-viral drugs & Vaccines | Submit

Drugs and vaccines used for the treatment of viral infections. The session includes virus life cycle, vaccinations (including policy and controversy), antiretroviral therapy, viral synthesis and new Drug repositioning research. The emergence of antimicrobial resistance poses a serious challenge to health care practitioners. Management and control of multidrug-resistant organisms should include good infection control practices, good antimicrobial stewardship programs and novel antimicrobials with new mechanisms of action.

  • Antiviral Innate Immunity
  • Antibody test
  • Testing kits
  • Immune drugs
  • Advanced Sequencing & Diagnostics

Vaccine & Drug Development | Submit

This session discusses about the drug discovery, Screening and designing. It also includes new clinical trials for the treatment and prevention of emerging infections, testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this disease.

  • Clinical trials
  • Various researches in different countries
  • New vaccines developing strategies

Treatment & Cure | Submit

Treatment of viral infections such involves patient care and moral support including antiretroviral therapy. This session includes management of infections, treatment and evaluation of patients.

  • Pain relievers
  • Medications
  • Isolation
  • Novel drugs/vaccines for treatment
  • Novel Therapeutic Agents

Risk factors & Prevention | Submit

Risk factors play a central part in prediction and prevention. Some infections can be prevented by avoiding direct contact with the contagious person. Infections can also be controlled and prevented by creating public awareness on various infectious diseases and their outbreaks.

  • Age
  • Higher risk for diabetes
  • Asthma & other lung disease
  • Some medical conditions
  • Use of certain medications
  • Poverty and crowding
  • Pregnancy
  • People aged 65 years and older
  • Heart conditions
  • Symptomatic treatment and monitoring
  • Oxygen therapy and monitoring
  • Treatment of co-infections
  • Acute respiratory distress syndrome (ARDS)
  • Prevention of complications

Management of COVID19 | Submit

As the coronavirus pandemic rapidly sweeps across the globe, it is inducing a considerable degree of emotional changes like fear, worry and concern in the population at large groups such as older adults, care providers and people with underlying health conditions. The psychological impact has increased stress or anxiety in all age groups and also has impact on people’s usual activities, routines or livelihoods.

  • Levels of loneliness
  • Depression
  • Harmful alcohol and drug use
  • Self-harm or suicidal behavior
  • Handling Social isolation
  • Emotional issues after recovery
  • Mental health and Covid 19
  • Handling Lockdown and emotional problems

Epidemics and outbreaks | Submit

Emerging new viruses and related infections had a global impact terribly. The number of high-threat infectious hazards continues to rise and some of these are re-emerging and others are new. While outbreaks of vaccine-preventable infectious diseases can have disastrous effects in areas with limited health infrastructure and resources, and where timely detection and response is difficult.

  • Pandemic outbreak at Wuhan
  • Cases and deaths
  • Viral testing & Transmission
  • Self – isolation
  • National & International response
  • Public health interventions in pandemics and epidemics
  • Travel restrictions

Coronavirus Pneumonia | Submit

Most people who get COVID-19 have mild or moderate symptoms like coughing, a fever, and shortness of breath. But some who catch the new coronavirus get severe pneumonia in both lungs. COVID-19 pneumonia is a serious illness that can be deadly. This session discussed about the symptoms, prevention and cure.

  • Novel Coronavirus-infected Pneumonia
  • COVID-19 Pneumonia Symptoms
  • COVID-19 Pneumonia Diagnosis
  • COVID-19 Pneumonia Prevention
  • Treatment and cure

Eradication of Coronavirus | Submit

Disease control is when we see a reduction in disease incidence and prevalence (new cases and current cases) as a result of public health measures. The reduction does not mean to zero cases, but rather to an acceptable level. For disease elimination, there must be zero new cases of the disease in a defined geographic area. There is no defined time period this needs to be sustained for – it usually depends on the incubation period of the disease (the time between being exposed to the virus and the onset of symptoms). Finally, disease eradication is when there are zero incidences worldwide of a disease following deliberate efforts to get rid of it. In this scenario, we no longer need intervention measures.

Speaker Guidelines

  • Speakers are encouraged to arrive at the venue at least an hour before their presentation is due to start. You will be given the opportunity to go through your slides in the break prior to your speech.
  • Oral sessions allow authors to present papers for discussion detailing their presenting for 20 minutes, with 5 minutes allocated for questionnaire.
  • Speakers are strongly encouraged to dress in business formals during presentations.
  • The conference secretariat will provide a letter of invitation upon request. This letter is to facilitate participant's travel and visa arrangements only.

Presentation Format

  • Technicians will assist you in pre-loading your presentation to the networked system either by their presentation in an USB flash drive/external device or authors can present using their own devices.
  • Prepare notes that highlight the salient points of your talk. Make sure your slides are readable, concise & uncluttered.
  • LCD projectors, Screens, Laser pointers and Microphones are provided.
  • Basic AV setup would be provided; slider with pointer, cordless mike, desktop mike, lapel, basic sound system.
  • Please stop when signaled by the Chair to do so.
  • Speakers who have video clips in their presentation should check the compatibility with the computer projection equipment

Abstract Submission Guidelines

  • Abstracts must be submitted on the understanding that they have not been presented elsewhere (except in the form of a thesis) and are not currently under consideration by another conference. The submitting speaker should ensure that the abstract publication has been approved by all other co-authors.
  • The abstracts must be submitted in English language (including title, abstract text, author names and affiliations).
  • Presenting author’s contact details including full mailing address, office phone number, email address and contact number
  • Name(s) of presenting author and co-authors: first name(s) or initials of first name(s), family name
  • Affiliation details of all authors: Department, institution/hospital, city, state (if relevant), country
  • The presenting author of an abstract must register for the Coronavirus 2021.
  • Abstract must be submitted online or can be e – mailed to the organizer.
  • You will receive a confirmation when the abstract has been received. Please contact the organizer if you did not receive confirmation within 2 working days.
  • You can submit your work in any broad themes (or) other topics related to coronavirus or virology.
  • All the abstracts must be submitted before the deadlines provided.
  • Abstracts will be published in the conference proceedings. 

Submit your abstract here